Thompson Siegel & Walmsley LLC Eton Pharmaceuticals, Inc. Transaction History
Thompson Siegel & Walmsley LLC
- $6.43 Billion
- Q4 2024
A detailed history of Thompson Siegel & Walmsley LLC transactions in Eton Pharmaceuticals, Inc. stock. As of the latest transaction made, Thompson Siegel & Walmsley LLC holds 128,039 shares of ETON stock, worth $2.16 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
128,039
Previous 115,030
11.31%
Holding current value
$2.16 Million
Previous $690,000
147.1%
% of portfolio
0.03%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding ETON
# of Institutions
74Shares Held
13.1MCall Options Held
284KPut Options Held
4.2K-
Opaleye Management Inc. Boston, MA2.85MShares$48 Million7.38% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA1.83MShares$30.8 Million1.12% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT1.12MShares$18.8 Million0.74% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.06MShares$17.9 Million0.0% of portfolio
-
Westside Investment Management, Inc.575KShares$9.69 Million1.61% of portfolio
About Eton Pharmaceuticals, Inc.
- Ticker ETON
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,297,000
- Market Cap $426M
- Description
- Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Carglumic Acid for th...